On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Boehringer Ingelheim (United States)

InstitutionResearch output, impact & collaborations

Boehringer Ingelheim (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Boehringer Ingelheim (United States)?

ScholarIQrecord summary

Boehringer Ingelheim (United States) is a research organisation in Ridgefield, US. OpenAlex records 6,479 works and 785,366 citations for it. 1,672 researchers list it as their most recent affiliation.

How many works does Boehringer Ingelheim (United States) have?

ScholarIQindexed works

Boehringer Ingelheim (United States) has 6,479 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Boehringer Ingelheim (United States) →

How many citations does Boehringer Ingelheim (United States) have?

ScholarIQcitation count

Boehringer Ingelheim (United States) has 785,366 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Boehringer Ingelheim (United States) →

How many researchers are at Boehringer Ingelheim (United States)?

ScholarIQresearcher count

Boehringer Ingelheim (United States) has 1,672 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Boehringer Ingelheim (United States)?

ScholarIQavg h-index

Boehringer Ingelheim (United States) has an average h-index of 26.2 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Boehringer Ingelheim (United States)?

ScholarIQror

The ROR for Boehringer Ingelheim (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for Boehringer Ingelheim (United States)?

ScholarIQopenalex

The OpenAlex for Boehringer Ingelheim (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Boehringer Ingelheim (United States)?

ScholarIQtop researchers by citations

Uli C. Broedl · Diabetes Treatment and Management

153 works33,090 citations

Andras J. Bauer · Neuroscience and Neuropharmacology Research

12 works20,294 citations

Janet Schnee · Atrial Fibrillation Management and Outcomes

56 works18,395 citations

Joseph Victoria · Viral gastroenteritis research and epidemiology

31 works3,206 citations

B.M.K. Donato · Health Systems, Economic Evaluations, Quality of Life

119 works1,093 citations

What are the most-cited papers on Boehringer Ingelheim (United States)?

ScholarIQmost cited works

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Silvio E. Inzucchi

New England Journal of Medicine. 201512,121 CitationsOPEN ACCESS

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

Christoph Wanner, Silvio E. Inzucchi, John M. Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Bernard Zinman

New England Journal of Medicine. 20163,655 CitationsOPEN ACCESS

Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus

David Z.I. Cherney, Bruce A. Perkins, Nima Soleymanlou, M Maione, Vesta Lai, Alana Lee, Nora Fagan, Hans J. Woerle, Odd Erik Johansen, Uli C. Broedl, Maximilian von Eynatten

Circulation. 20131,319 CitationsOPEN ACCESS

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients

Ele Ferrannini, Elza Muscelli, Silvia Frascerra, Simona Baldi, Andrea Mari, Tim Heise, Uli C. Broedl, Hans‐Juergen Woerle

Journal of Clinical Investigation. 20141,137 CitationsOPEN ACCESS

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME <sup>®</sup> trial

David Fitchett, Bernard Zinman, Christoph Wanner, John M. Lachin, Stefan Hantel, Afshin Salsali, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Silvio E. Inzucchi

European Heart Journal. 2016906 CitationsOPEN ACCESS

How much of the research on Boehringer Ingelheim (United States) is open access?

ScholarIQopen access share

92%OPEN ACCESS

Gold

17%

Green

17%

Hybrid

17%

Bronze

42%

Closed